investorscraft@gmail.com

Intrinsic Value of Collegium Pharmaceutical, Inc. (COLL)

Previous Close$36.35
Intrinsic Value
Upside potential
Previous Close
$36.35

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-12-31 and quarterly data as of 2023-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %67.6NaN
Revenue, $464NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m431NaN
Operating income, $m33NaN
EBITDA, $m172NaN
Interest expense (income), $mNaN
Earnings before tax, $m-29NaN
Tax expense, $m-4NaN
Net income, $m-25NaN

BALANCE SHEET

Cash and short-term investments, $m174NaN
Total assets, $m1174NaN
Adjusted assets (=assets-cash), $m1000NaN
Average production assets, $m504NaN
Working capital, $m-14NaN
Total debt, $m701NaN
Total liabilities, $m979NaN
Total equity, $m195NaN
Debt-to-equity ratio3.598NaN
Adjusted equity ratio0.184NaN

CASH FLOW

Net income, $m-25NaN
Depreciation, amort., depletion, $m139NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m124NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-2NaN
Free cash flow, $m126NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m-14
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount